how can i get approved for glp 1 GLP-1s Nutritional priorities to support GLP-1

Wegovy, which also contains Semaglutide GLP-1 but at a higher dosage than Ozempic, is specifically approved for obesity treatment and chronic weight management

MHRA Updated Semaglutide Guidance (GOV.UK, February 2026) 10

* Increases satiety, reducing food intake and promoting weight loss

In 2025, the company reported a +2.39% YoY growth in revenue, reflecting portfolio concentration: Biktarvy ($14.33B) continues to dominate the HIV segment with strong patient uptake, Descovy ($2.75B) remains a key contributor in both treatment and prevention, while Genvoya ($1.49B) continues its gradual decline as patients transition to newer regimens highlighting a shift within its HIV portfolio

Beyond the scale: metabolic benefits compared Weight loss is the headline

Though we conducted a longer-term follow-up analysis in the T2D population, future studies are necessary to evaluate long-term associations of semaglutide in patients with obesity and patients with T2D